Shanghai MicroPort MedBot (Group) Co., Ltd. (02252) disclosed its monthly return for January 2026, indicating that the total authorized share capital remained at RMB 1,031,330,331. The domestic shares stood at 6,599,543, while the H shares remained at 1,024,730,788, with the par value of RMB 1 per share.

Throughout January, there were no changes in the issued share capital, and the company did not hold or cancel any treasury shares. The public float requirement for the H shares was met according to applicable listing rules. Regarding the share option scheme, a maximum of 95,199,428 H shares remain available to be issued; however, no new shares were issued under this scheme during the reporting period.